| Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy Y Wang, Y Xie, J Li, ZH Peng, Y Sheinin, J Zhou, D Oupický ACS nano 11 (2), 2227-2238, 2017 | 425 | 2017 |
| Recent advances in delivery of drug–nucleic acid combinations for cancer treatment J Li, Y Wang, Y Zhu, D Oupický Journal of Controlled Release 172 (2), 589-600, 2013 | 228 | 2013 |
| Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy RL Sleightholm, BK Neilsen, J Li, MM Steele, RK Singh, MA Hollingsworth, ... Pharmacology & therapeutics 179, 158-170, 2017 | 150 | 2017 |
| Endosomolytic and tumor-penetrating mesoporous silica nanoparticles for siRNA/miRNA combination cancer therapy Y Wang, Y Xie, KV Kilchrist, J Li, CL Duvall, D Oupický ACS Applied Materials & Interfaces 12 (4), 4308-4322, 2020 | 121 | 2020 |
| Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy Y Xie, Y Hang, Y Wang, R Sleightholm, DR Prajapati, J Bader, A Yu, ... ACS nano 14 (1), 255-271, 2020 | 112 | 2020 |
| Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors DS Manickam, J Li, DA Putt, QH Zhou, C Wu, LH Lash, D Oupický Journal of Controlled Release 141 (1), 77-84, 2010 | 110 | 2010 |
| Polymeric drugs: Advances in the development of pharmacologically active polymers J Li, F Yu, Y Chen, D Oupický Journal of Controlled Release 219, 369-382, 2015 | 99 | 2015 |
| Bioreducible polycations in nucleic acid delivery: past, present, and future trends D Oupický, J Li Macromolecular bioscience 14 (7), 908-922, 2014 | 98 | 2014 |
| Dual‐function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion J Li, Y Zhu, ST Hazeldine, C Li, D Oupický Angewandte Chemie 124 (35), 8870-8873, 2012 | 95 | 2012 |
| Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy Y Xie, T Murray-Stewart, Y Wang, F Yu, J Li, LJ Marton, RA Casero Jr, ... Journal of Controlled Release 246, 110-119, 2017 | 91 | 2017 |
| Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC–ESI–MS/MS: An application for pharmacokinetic studies YS Chhonker, RL Sleightholm, J Li, D Oupický, DJ Murry Journal of Chromatography B 1072, 320-327, 2018 | 73 | 2018 |
| Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor J Li, D Oupický Biomaterials 35 (21), 5572-5579, 2014 | 63 | 2014 |
| Combining fluorination and bioreducibility for improved siRNA polyplex delivery G Chen, K Wang, Q Hu, L Ding, F Yu, Z Zhou, Y Zhou, J Li, M Sun, ... ACS applied materials & interfaces 9 (5), 4457-4466, 2017 | 58 | 2017 |
| Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early-and Late-Stage Metastatic Breast Cancer G Chen, Y Wang, P Wu, Y Zhou, F Yu, C Zhu, Z Li, Y Hang, K Wang, J Li, ... ACS nano 12 (7), 6620-6636, 2018 | 55 | 2018 |
| Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes Y Wang, J Li, Y Chen, D Oupický Biomaterials science 3 (7), 1114-1123, 2015 | 54 | 2015 |
| Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy Y Wang, C Wang, Y Ding, J Li, M Li, X Liang, J Zhou, W Wang Colloids and Surfaces B: Biointerfaces 148, 533-540, 2016 | 47 | 2016 |
| Development of Functional Poly (amido amine) CXCR4 Antagonists with the Ability to Mobilize Leukocytes and Deliver Nucleic Acids Y Wang, ST Hazeldine, J Li, D Oupický Advanced healthcare materials 4 (5), 729-738, 2015 | 45 | 2015 |
| Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells A Wani, GHL Savithra, A Abyad, S Kanvinde, J Li, S Brock, D Oupický Scientific reports 7 (1), 1-11, 2017 | 44 | 2017 |
| Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions Z Li, G Chen, L Ding, Y Wang, C Zhu, K Wang, J Li, M Sun, D Oupicky Molecular Therapy 27 (12), 2100-2110, 2019 | 41 | 2019 |
| Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness Y Xie, Y Wang, J Li, Y Hang, L Jaramillo, CJ Wehrkamp, MA Phillippi, ... Theranostics 8 (16), 4305, 2018 | 40 | 2018 |
David OupickýUniversity of Nebraska Medical CenterVerified email at unmc.edu
